发明公开
EP2329849A1 Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
有权
α-2肾上腺素受体激动剂和用于治疗或预防皮肤的炎症性疾病的甾体抗炎剂的组合
- 专利标题： Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
- 专利标题（中）： α-2肾上腺素受体激动剂和用于治疗或预防皮肤的炎症性疾病的甾体抗炎剂的组合
-
申请号： EP09176392.0申请日： 2009-11-18
-
公开(公告)号： EP2329849A1公开(公告)日： 2011-06-08
- 发明人: Jomard, André , Delamadeleine, Françoise
- 申请人： Galderma Research & Development
- 申请人地址： Les Templiers 2400 Route des Colles 06410 Biot FR
- 专利权人： Galderma Research & Development
- 当前专利权人： Galderma Research & Development
- 当前专利权人地址： Les Templiers 2400 Route des Colles 06410 Biot FR
- 代理机构： Allab, Myriam
- 主分类号： A61K45/06
- IPC分类号： A61K45/06 ; A61K31/00 ; A61K31/196 ; A61K31/498 ; A61K9/00 ; A61K9/06 ; A61P17/00 ; A61P17/04 ; A61P17/06 ; A61P17/10
摘要：
Methods and compositions for improved treatment and prevention of an inflammatory skin disorder or a sign and/or symptom associated with the skin disorder are described. The methods involve topical application to the skin a combination of a therapeutically effective amount of an α2 adrenergic receptor agonist, such as brimonidine, and a therapeutically effective amount of a non-steroidal anti-inflammatory agent, such as diclofenac.
公开/授权文献
信息查询
